Experience with Contraceptive Dosage Forms and Interest in Novel PrEP Technologies in Women

Claudia Juliette Jansen van Vuuren(Centre for the AIDS Programme of Research in South Africa), Leila E. Mansoor(Centre for the AIDS Programme of Research in South Africa), Lara Lewis(Centre for the AIDS Programme of Research in South Africa), Halima Dawood(Centre for the AIDS Programme of Research in South Africa), Ishana Harkoo(Centre for the AIDS Programme of Research in South Africa)
AIDS and Behavior
May 23, 2023
10.1007/s10461-023-04072-6
Cited by 6

Related Papers

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
|New England Journal of Medicine|2024|471
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis
|International Journal of Epidemiology|2013|204
High Nasopharyngeal Pneumococcal Density, Increased by Viral Coinfection, Is Associated With Invasive Pneumococcal Pneumonia
|The Journal of Infectious Diseases|2014|197
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
|The Lancet HIV|2021|180
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
|The Lancet HIV|2020|177